ARCHIVES

Risk of Relapse Continues After Five Years of Therapy

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

NCCS Networker Volume 4 Issue 2, Spring 1990

April 13, 1990

Sen. Mack Calls For “National Crusade” Against Cancer.

May 26, 2000

FDA Forms Office of Combination Products;

January 10, 2003

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010